Free Trial

Vaccine News Spurs Massive Risk-On Surge

US TSYS SUMMARY

Already trading with a risk-on tone following weekend news former VP Biden now President Elect, rates gapped lower/equities surged to new all-time highs before the NY open after Pfizer announced vaccine is 90% effective in combatting Covid-19.

  • Heavy Tsy volumes (TYZ 175% 20D avg, FVZ 184% 20D avg). Obviously better selling included huge Blocks (-23,500 TYZ 137-19 for example) helped push 10YY to eight month high of 0.9730% midmorning. Curve steepeners back on (+10,865 TYZ vs. -4,553 USZ)
  • S&P futures extended rally to new high of 3668.0 (appr +155.0) after the open but scaled back to +85.0 after the close.
  • After holding to sidelines do to election uncertainty, corporate issuance returned with a bang w/ $18.5B, lion's share tied to $7B Bristol-Myers Squibb 6pt. US Tsy $54B 3Y Note auction (91282CAW1) stopped through: awarded 0.250% (0.193% last month) vs. 0.252% WI, on a bid/cover 2.40 vs. 2.44 previous.
  • The 2-Yr yield is up 2.8bps at 0.1806%, 5-Yr is up 8.3bps at 0.444%, 10-Yr is up 13.6bps at 0.9542%, and 30-Yr is up 14.6bps at 1.7464%.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.